Results 31 to 40 of about 257,683 (336)

Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott–Aldrich Syndrome Using Their Father as the Donor

Frontiers in Pediatrics, 2021
Wiskott–Aldrich syndrome (WAS) is an X-linked genetic disorder with a variable phenotypic expression that includes thrombocytopenia, eczema, and immunodeficiency. Some patients may also exhibit autoimmune manifestations.
Jasmine Smith, Jasmine Smith, Jessica Hass Alfonso, Jessica Hass Alfonso, Naresh Reddivalla, Naresh Reddivalla, Pablo Angulo, Pablo Angulo, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis   +13 more
doaj   +1 more source

Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.

Journal of Endocrinology, 2019
Cancer therapy can cause off-target effects including ovarian damage, which may result in primary ovarian insufficiency in girls and premenopausal women.
Y. Luan, Maxwell E Edmonds, T. Woodruff, So-Youn Kim   +3 more
semanticscholar   +1 more source

Stimulation of humoral and cell-mediated immunities in healthy and cyclophosphamide-induced immunosuppressed rats by the lyophilized Houttuynia cordata fermented drink

Food and Agricultural Immunology, 2021
Houttuynia cordata fermented drinks (HCFDs) are dietary liquid supplements widely marketed and consumed for immune enhancement. In this study, the acute oral toxicity and immunostimulatory activity of the selected lyophilized HCFD in healthy and ...
Suppawit Utaiwat, Gulsiri Senawong, Kanoknan Khongsukwiwat, Khanutsanan Woranam, Jeerati Prompipak, Jintana Sattayasai, Thanaset Senawong   +6 more
doaj   +1 more source

Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis

Case Reports in Ophthalmology, 2010
Purpose: To report the effect of long-term therapy with the alkylating agent cyclophosphamide in a case with serpiginous choroiditis and thus to contribute to the previously reported few cases showing the beneficial effect of long-term cyclophosphamide ...
Ozlem G. Sahin
doaj   +1 more source

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding

Frontiers in Immunology, 2019
Post-transplantation cyclophosphamide (PTCy) has been highly successful at preventing severe acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). The clinical application of this approach was based
N. S. Nunes, C. Kanakry
semanticscholar   +1 more source

Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers: A Systematic Review and Meta-analysis.

JAMA Oncology, 2019
Importance Use of haploidentical (HAPLO) stem cell transplantation with posttransplant cyclophosphamide is rapidly increasing in adults with hematologic cancers.
N. Gagelmann, A. Bacigalupo, A. Rambaldi, D. Hoelzer, J. Halter, J. Sanz, F. Bonifazi, E. Meijer, M. Itälä-Remes, M. Marková, C. Solano, N. Kröger   +11 more
semanticscholar   +1 more source

Efficacy of two intensive decontamination protocols and their effects after 30 days on environmental contamination by cyclophosphamide

Pharmaceutical Technology in Hospital Pharmacy, 2021
To evaluate the efficacy of two decontamination protocols on cyclophosphamide surface contamination and to explore its lasting effect 30 days later.
Delafoy Clémence, Chabut Claire, Tanguay Cynthia, Bussières Jean-François   +3 more
doaj   +1 more source

Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model

Journal of Ovarian Research, 2018
BackgroundIn recent years, cancer rates have been rising among reproductive-age women. Thus, chemotherapy exposure has become an important cause of premature ovarian failure (POF).
R. Melekoğlu, O. Çiftçi, S. Eraslan, A. Çetin, N. Başak   +4 more
semanticscholar   +1 more source

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Journal of Clinical Oncology, 2018
Purpose Intermediate-risk rhabdomyosarcoma (RMS) includes patients with either nonmetastatic, unresected embryonal RMS (ERMS) with an unfavorable primary site or nonmetastatic alveolar RMS (ARMS).
D. Hawkins, Yueh-Yun Chi, James R. Anderson, Jing Tian, C. Arndt, L. Bomgaars, S. Donaldson, A. Hayes-Jordan, L. Mascarenhas, M. B. McCarville, J. McCune, G. McCowage, L. Million, C. Morris, D. Parham, D. Rodeberg, E. Rudzinski, M. Shnorhavorian, S. Spunt, S. Skapek, L. Teot, S. Wolden, T. Yock, W. Meyer   +23 more
semanticscholar   +1 more source

Administration of cyclophosphamide to rats induces pica and potentiates 5-hydroxytryptamine synthesis in the intestine without causing severe intestinal injury

Journal of Pharmacological Sciences, 2021
The effects of cyclophosphamide on 5-hydroxytryptamine (5-HT) synthesis in the intestinal tissue of rats were investigated. Rats received 120 mg/kg cyclophosphamide intraperitoneally as a single administration, and kaolin and food intake was measured by ...
Akihisa Kamiya, Takuji Machida, Megumi Hirano, Maiko Machida, Saki Shiga, Naoya Hamaue, Masahiko Hirafuji, Kenji Iizuka   +7 more
doaj